Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.21.1
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Totals 10,453,343 3,467,654
Options to Purchase Common Stock [Member]    
Totals 1,845,282 998,814
Restricted stock Unvested [Member]    
Totals 1,244,503
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO Merger Common Stock Purchase Warrants and post-merger AYRO warrants issued [Member]    
Totals 7,361,083 461,647
Series H, H-3, H-6, and Pre-merger AYRO Seed Preferred Stock [Member]    
Totals 2,475 2,007,193